Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?
about
Non-pharmaceutical management of respiratory morbidity in children with severe global developmental delayEmerging therapies and challenges in spinal muscular atrophyPreventable Infections in Children with Leukodystrophy.Observational study of spinal muscular atrophy type I and implications for clinical trials.Nutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type IUse of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits.Determinants of health care use in a population-based leukodystrophy cohort.Pulmonary Manifestations of Neuromuscular Diseases.The economic burden of spinal muscular atrophy.Clinical management of Krabbe disease.Children and Young Adults Who Received Tracheostomies or Were Initiated on Long-Term Ventilation in PICUsIndirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.A multi-institutional analysis of children on long-term non-invasive respiratory support and their outcomes.Long-term Non-Invasive Ventilation in Infants: A Systematic Review and Meta-Analysis.Physician driven variation in the care of children with spinal muscular atrophy type 1.The Effect of Noninvasive Positive Pressure Ventilation on Pneumonia Hospitalizations in Children With Neurological Disease.Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives.
P2860
Q24193095-353A794C-EE13-45A1-82CC-5FF87037AF01Q33578135-C00EF23B-E723-411A-88F6-DD91CA068985Q33777276-5A275C8C-BFD0-4B24-863C-053143DEC2F8Q34135750-654D56C0-EC66-4D87-92C8-3D4BE426B6FFQ35101826-56F3B24D-4749-4242-A306-53382C35089AQ35238315-654B2649-7EB4-47A6-87EF-93ECEEAC01D6Q35610032-392AD5B0-EB9D-4218-BD75-0BE5F33AFAE2Q36545199-ED5A8A35-3784-46CE-9D10-FA38BA5500DAQ38551822-53041407-5828-4B00-B24A-787BF193E1BBQ38855498-EC49322B-9A61-4C47-B292-F5B885A6DE1DQ38957260-9B4CB858-9301-486D-8ED7-99870E68183AQ42367219-4B3CE945-F4C6-434A-A1EB-2377B982ADFCQ47144354-72B00FA6-B2BB-4110-B97A-3E4BF845E4FCQ47654921-F1B5E1FB-53C0-484C-95EB-0FF9357BC0E6Q50317854-F93E4BE7-F342-4F23-A412-E6DA25893105Q51448823-008018C2-230B-4F3E-8E11-080262E74327Q55034908-A7E84168-8874-4DF5-A0B3-9B809985B58BQ55274805-D6BFD2C6-703D-4A55-8BC3-775C1150959B
P2860
Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@ast
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@en
type
label
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@ast
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@en
prefLabel
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@ast
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@en
P2093
P2860
P1476
Spinal muscular atrophy type 1 ...... sociated with longer survival?
@en
P2093
Kathryn J Swoboda
Michael Mundorff
Rajendu Srivastava
Richard Holubkov
Susan L Bratton
Tara J Lemoine
P2860
P304
P356
10.1097/PCC.0B013E3182388AD1
P577
2012-05-01T00:00:00Z